Article Details
Retrieved on: 2021-08-11 15:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Specifically, BioNTech procured Kite's neoantigen TCR cell therapy R&D platform along with its Maryland-based manufacturing facility.
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here